![](/img/cover-not-exists.png)
Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients
Joshua C. Bis, Nicholas L. Smith, Bruce M. Psaty, Susan R. Heckbert, Karen L. Edwards, Rozenn N. Lemaitre, Thomas Lumley, Frits R. RosendaalVolume:
16
Year:
2003
Language:
english
Pages:
1018
DOI:
10.1016/j.amjhyper.2003.07.018
File:
PDF, 90 KB
english, 2003